Cardiovascular Disease Clinical Trial
Official title:
The Use of Text Messaging to Improve the Hospital-community Transition and Prevent Readmission in Patients With Cardiovascular Disease (Txt2Prevent)
Participants will be recruited during their hospitalization for either heart attack or unstable angina and will be randomly assigned to either a text message program (Txt2Prevent) or usual care. They will be texted for the first 60-days after discharge. Texts will include topics regarding self-management and discharge protocols such as reminders to make an appointment with their general practitioner or to refill medication prescriptions. After 60 days, the two groups will be compared for hospital readmission rates, quality of life, medication adherence, and self-management.
Cardiovascular disease is one of the leading causes for hospitalization and death in Canada.
Being discharged is often a challenging and overwhelming time. Sometimes patients are
readmitted to the hospital shortly in the months following their discharge. Some of these
readmissions are due to information transfer being poor or insufficient.
Previous studies have looked at whether text messaging can be a simple, cost-effective way
to help patients. Therefore, we wish to investigate the effectiveness of using text
messaging to help heart patients after they are discharged from the hospital.
The goal of this study is to determine the impact of a pilot text-messaging intervention
program (Txt2Prevent) that supports coronary syndrome (heart attack and unstable angina)
patients for 60 days after their hospital discharge. The program will include information
about follow-up care, medication use, and healthy lifestyle behaviours. The texts will be
sent at relevant times during the patients' recovery.
The primary objective is compare self-management between the usual care patients versus the
Txt2prevent patients. We hypothesize that the Txt2Prevent group will have better
self-management than the usual care group.
The secondary objective is compare medication adherence, and health-related quality of life
as well as readmission and mortality rates between the two patient groups. We hypothesize
that the Txt2Prevent group will have better outcomes for these variables.
The study population is acute coronary syndrome patients at St. Paul's hospital who are
discharged. Participants will be randomly assigned to one of two groups—a usual care group
and the usual care plus the Txt2Prevent text messaging program group. All participants will
undergo a baseline assessment that includes:
- Demographics, medical history, medication use and technology use information
- Self-management skills
- Health-related quality of life
After 60 days, participants will be contacted again to perform a follow up assessment that
includes:
- Information on readmission, medication use, the use of health services such as cardiac
rehab
- Self-management skills
- Health-related quality of life
- Medication adherence
In both the baseline and follow-up assessments, information may be obtained from the
patient's medical chart or records (e.g. medical history) or self-report.
After the intervention, some intervention participants will be contacted to complete a
semi-structured interview about their experiences with the Txt2Prevent program.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|